We are live on ! Find out more

Stocks Most Commonly
Held By Funds

Funds Holding Holding in Top 10 New Positions Closed Positions Increased Positions Reduced Positions Call Options Put Options
Name Funds
holding 		Growth Growth % Return since
31 Dec ‘17
PEZ icon
176
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.5M
30 +7 +30% 103%
DVYA icon
177
iShares Asia/Pacific Dividend ETF
DVYA
$71.6M
26 +6 +30% 2.04%
GSJY icon
178
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$84.5M
13 +3 +30% 57%
RCG
179
RENN Fund
RCG
$21.2M
13 +3 +30% 101%
BRID icon
180
Bridgford Foods
BRID
$57.6M
13 +3 +30% 49.4%
DHF
181
BNY Mellon High Yield Strategies Fund
DHF
$171M
61 +14 +30% 29.6%
MVV icon
182
ProShares Ultra MidCap400
MVV
$153M
35 +8 +30% 113%
OEFA
183
ALPS O'Shares International Developed Quality Dividend ETF
OEFA
$36.5M
22 +5 +29% 39.7%
SJB icon
184
ProShares Short High Yield
SJB
$51.8M
22 +5 +29% 34.1%
GGZ
185
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$123M
53 +12 +29% 26.8%
PGHY icon
186
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$222M
53 +12 +29% 17.9%
GLO
187
Clough Global Opportunities Fund
GLO
$250M
62 +14 +29% 46.3%
DOG
188
ProShares Short Dow30
DOG
$100M
40 +9 +29% 63.8%
PIE icon
189
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$237M
58 +13 +29% 45%
SPXE icon
190
ProShares S&P 500 ex-Energy ETF
SPXE
$83.6M
9 +2 +29% 185%
SPDN icon
191
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$221M
9 +2 +29% 71.5%
CNTY icon
192
Century Casinos
CNTY
$34M
96 +21 +28% 86.7%
FLC
193
Flaherty & Crumrine Total Return Fund
FLC
$174M
32 +7 +28% 22.8%
CRBP icon
194
Corbus Pharmaceuticals
CRBP
$166M
88 +19 +28% 95.8%
GNT
195
GAMCO Natural Resources, Gold & Income Trust
GNT
$135M
28 +6 +27% 20.4%
EDF
196
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$167M
28 +6 +27% 67.3%
PSCE icon
197
Invesco S&P SmallCap Energy ETF
PSCE
$98.6M
28 +6 +27% 25.1%
CLIR icon
198
ClearSign Technologies
CLIR
$24.3M
28 +6 +27% 89.3%
PGP
199
PIMCO Global StockPLUS & Income Fund
PGP
$98.1M
28 +6 +27% 44.9%
GRCE
200
Grace Therapeutics
GRCE
$33.8M
14 +3 +27% 95.4%
6 7
8
9 10